کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3922173 1599900 2006 5 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی زنان، زایمان و بهداشت زنان
پیش نمایش صفحه اول مقاله
Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome
چکیده انگلیسی

ObjectiveTo evaluate prospectively the prognostic factors for ovulatory responses following clomiphene citrate (CC) administration in polycystic ovary syndrome (PCOS).Study designFifty-nine infertile patients with a diagnosis of PCOS were recruited. Ovulation was induced using 100 mg/day CC administered daily from days 5 to 9 of the cycle. Endocrine and metabolic parameters between responder and non-responder groups were analyzed.ResultsFor a 75-g fasting glucose load (75-g OGTT), blood glucose levels at 60 and 120 min, the area under the curve (AUC) and blood insulin levels at 120 min in the non-responder group (n = 25) were significantly higher than those in the responder group (n = 34), although the measurements of fasting blood glucose and insulin were not significantly different between the two groups. In the receiver operating characteristic curves, the most appropriate cutoff point was 120 mg/dl for the blood glucose level at 120 min and 9000 for the blood glucose × insulin level at 120 min. There were no significant differences in the clinical characteristics or in the endocrine and metabolic parameters between conceived (n = 9) and non-conceived groups (n = 21).ConclusionThe levels of blood glucose and blood glucose × insulin at 120 min after 75-g OGTT could be good biochemical markers of CC resistance in PCOS. No predictors of conception following CC therapy were identified by this study.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Obstetrics & Gynecology and Reproductive Biology - Volume 126, Issue 2, June 2006, Pages 201–205
نویسندگان
, , , , , ,